Eisai
4523.T
£20.74
Share price
0.95%
Change (1 day)
-34.27%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
EPS for Eisai (4523.T)
EPS in 2023 (TTM): £1.80
According to Eisai's latest financial reports the company's current EPS (TTM) is £1.69. In 2022 the company made an earnings per share (EPS) of £1.24 a decrease over its 2021 EPS that were of £5.52.
EPS history for Eisai from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | £1.80 | 45.16% |
| 2022 | £1.24 | -77.48% |
| 2021 | £5.52 | -41.88% |
| 2020 | £9.49 | -0.94% |
| 2019 | £9.58 | 52.59% |
| 2018 | £6.28 | 124.17% |
| 2017 | £2.80 | -49.42% |
| 2016 | £5.54 | 37.08% |
| 2015 | £4.04 | -11.75% |
| 2014 | £4.58 | -3.23% |
| 2013 | £4.73 | -18.56% |
| 2012 | £5.81 | -15.51% |
| 2011 | £6.87 | -3.75% |
| 2010 | £7.14 | -1.36% |
| 2009 | £7.24 |